Tricuspid Regurgitation clinical trials
Access comprehensive clinical trial information for Tricuspid Regurgitation through Pure Global AI's free database. This collection includes 49 clinical trials across multiple phases including N/A, Not Applicable, Phase 1. Currently, 22 trials are actively recruiting participants.
Research for Tricuspid Regurgitation is being conducted in United States of America, China, Italy and 7+ other countries. Leading sponsors include Michele De Bonis and Shanghai Huihe Medical Technology Co., Ltd. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 49 clinical trials studying Tricuspid Regurgitation, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Michele De Bonis, Shanghai Huihe Medical Technology Co., Ltd, Hangzhou Valgen Medtech Co., Ltd, among others.